Sangamo Therapeutics Direct Offering Aims to Raise $24M
Friday, 22 March 2024, 12:21
Sangamo Therapeutics Raises Capital Through Direct Offering
Sangamo Therapeutics has initiated a securities purchase agreement in an attempt to raise $24M by selling shares and pre-funded warrants. The decision has led to a drop in the company's share value.
Key Points:
- Sangamo Therapeutics is seeking to boost its capital through the offering.
- Investors' reaction to the news has resulted in a decline in share prices.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.